The Company finishes 2025 with strong Q4 performance, expects 20-22% revenue growth in 2026, and promotes Ross Muken to CEO BOSTON and ROLLE, Switzerland, Jan. 12, 2026 /PRNewswire/ -- SOPHiA GENETICS ...
CSGA Board of Directors announced a leadership transition, with Executive Director Doug Miller stepping down from his role effective the end of March 2026. CSGA is strong, stable, and ready for the ...
The Company finishes 2025 with strong Q4 performance, expects 20-22% revenue growth in 2026, and promotes Ross Muken to CEO Revenue of approximately $77 million, representing an increase of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results